Skip to main content

Generics

  • Study: People with optimal levels of vitamin D have lower diabetes incidence

    NEUHERBERG, Germany — Scientists at the Helmholtz Zentrum München have shown that people with good vitamin D status have a lower risk of developing Type 2 diabetes, according to a study released Sept. 30.

  • AstraZeneca settles with generic drug makers over Seroquel XR

    NEW YORK — Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.

    The company settled with Handa Pharmaceuticals and also with Accord Healthcare and Intas Pharmaceuticals over two generic versions of the bipolar disorder and schizophrenia treatment Seroquel XR (quetiapine fumarate) extended-release tablets.

  • Watson files for approval of generic painkiller

    PARSIPPANY, N.J. — Watson Pharmaceuticals is looking to become the first to market a generic version of a painkiller made by Pfizer, the drug maker said Friday.

    Watson said it filed a regulatory approval application with the Food and Drug Administration for morphine sulfate and naltrexone hydrochloride extended-release capsules in the 30-mg/1.2-mg, 50-mg/2-mg, 60-mg/2.4-mg, 80-mg/3.2-mg and 100-mg/4-mg strengths. The drug is a generic version of Embeda, made by Pfizer subsidiary King Pharmaceuticals.

  • Branded-to-generic shift impacts Fred's September comps

    MEMPHIS, Tenn. — Fred’s posted a 1% gain in sales, to $17.5 million, for the five weeks ended Oct. 1.

    Comparable store sales for September increased 1.1%; comparable store sales were flat in the year-earlier month. The September total sales comparison was adversely affected by store-closing sales that occurred last year during the month.

  • Harris Teeter to host grand reopening featuring flu shots, health screenings

    CHARLOTTE, N.C. — Harris Teeter on Oct. 8 and 9 will host a grand reopening celebration featuring a free sampling event at its Norfolk, Va., Harris Teeter, the grocer announced Thursday.

    As part of the events, Harris Teeter will host a flu shot clinic at the pharmacy throughout the weekend. Free health screenings also will be conducted from 11 a.m. through 4 p.m. Shoppers can receive blood-glucose testing, biometric measurement and a health risk assessment.

  • Study: Too much TV may be an indicator of poor blood-glucose control

    ALEXANDRIA, Va. — Type 1 diabetics who watch the most television have poorer blood-sugar control on average, according to a study published online Sept. 16 by the American Diabetes Association's journal Diabetes Care.

    In the cross-sectional study, self-report questionnaires were used to assess media consumption habits, physical activity and socioeconomic status in 296 children, adolescents and young adults with Type 1 diabetes.

  • Perrigo receives tentative FDA approval for generic scalp dermatosis drug

    ALLEGAN, Mich. — The Food and Drug Administration has granted tentative approval to a drug made by Perrigo for dermatosis of the scalp.

    Perrigo's clobetasol propionate emulsion foam in the 0.05% strength is a generic version of Stiefel Labs' Olux-E Foam. Sales for the branded version of the drug were $40 million during the 12-month period ended in September, according to Wolters Kluwer.

  • AccuDial expands packaging portfolio with Stephen Key acquisition

    PALM BEACH GARDENS, Fla. — AccuDial Pharmaceutical on Tuesday acquired Stephen Key Design in a move that will expand AccuDial’s patent portfolio to more than 50 patents for weight-based dosing and other extended content rotating labels, which add 75% more labeling space to a container.

X
This ad will auto-close in 10 seconds